Author

Van Bui

h-index 4 View on Semantic Scholar

We have 1 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Lonvoguran ziclumeran: a CRISPR-CAS9-based gene therapy for the treatment of hereditary angioedema

Lonvo-z uses CRISPR/Cas9 technology to permanently reduce production of prekallikrein that triggers swelling attacks in HAE, potentially providing long-lasting disease control after a single treatment.

L. Luong, Shane Stone, Van Bui et al. · Expert Opinion on Investigat... · 0 citations